ACHV Price / Book | Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc. (ACHV) Price / Book

2026-03-31: Price/Book Ratio 14.66.
2025-12-31: Price/Book Ratio 12.3.
2025-09-30: Price/Book Ratio 4.95.
2025-06-30: Price/Book Ratio 2.69.

Historical market capitalization divided by filed shareholder equity.

Available history: 2010-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-03-31	14.66
2025-12-31	12.3
2025-09-30	4.95
2025-06-30	2.69
2025-03-31	9.01
2024-12-31	5.84
2024-09-30	5.19
2024-06-30	3.82
2024-03-31	3.15
2023-09-30	22.54
2023-06-30	11.29
2023-03-31	275.23
2022-12-31	5.28
2022-09-30	30.69
2022-06-30	3.59
2022-03-31	3.35
2021-12-31	2.62
2021-09-30	2.32
2021-06-30	2.08
2021-03-31	2.37
2020-12-31	1.33
2020-09-30	1.18
2020-06-30	1.07
2020-03-31	13.81
2019-12-31	0.87
2019-09-30	33.84
2019-06-30	27.17
2019-03-31	42.61
2018-12-31	10.29
2018-09-30	21.8
2018-06-30	19.49
2018-03-31	527.19
2017-12-31	20.26
2017-09-30	436.44
2017-06-30	1,819.64
2017-03-31	1,832.78
2016-12-31	38.28
2016-09-30	1,379.37
2016-06-30	2,337.12
2016-03-31	1,307.92
2015-12-31	43,131.63
2015-09-30	3,770.59
2015-06-30	4,442.81
2015-03-31	3,573.47
2014-12-31	3,346.16
2014-09-30	3,217.52
2014-06-30	4,830.01
2014-03-31	12,893.35
2013-12-31	7,252.16
2013-09-30	6,887.89
2013-06-30	6,007.58
2013-03-31	6,067.62
2012-12-31	6,389.92
2012-09-30	6,549.49
2012-06-30	5,767.38
2012-03-31	5,441.35
2011-12-31	8,152.1
2011-09-30	5,251.08
2011-06-30	10,344.45
2010-12-31	8,114.72

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
QuidelOrtho Corp (QDEL)	United States	$0.733B	-0.90
Alpha Teknova, Inc. (TKNO)	United States	$0.500B	-18.12
MYRIAD GENETICS INC (MYGN)	United States	$0.397B	-4.84
Insight Molecular Diagnostics Inc. (IMDX)	United States	$0.129B	-3.90
IMMUCELL CORP /DE/ (ICCC)	United States	$0.091B	116.10
BIOMERICA INC (BMRA)	United States	$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)	United States	$0.008B	-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)	United States	$0.006B
VOLITIONRX LTD (VNRX)		$0.003B	-0.64
Intellia Therapeutics, Inc. (NTLA)	United States	$1.705B	-5.92